Neonatal iron nutrition

Seminars in Neonatology

Volumn 6, Issue 5, 2001, Pages 425-435

  Rao, Raghavendra ^a   Georgieff, Michael K ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Infant; Iron administration and dosage; Iron adverse effects; Iron deficiency; Iron toxicity; Newborn; Premature

Indexed keywords

ERYTHROPOIETIN; IRON;

ANTIOXIDANT ACTIVITY; BREAST MILK; COGNITIVE DEVELOPMENT; HUMAN; INFANT NUTRITION; IRON DEFICIENCY; NEWBORN; PERINATAL MORBIDITY; PHLEBOTOMY; PREMATURITY; REVIEW;

EID: 0035740247     PISSN: 10842756     EISSN: None     Source Type: Journal    
DOI: 10.1053/siny.2001.0063     Document Type: Article

References (108)

1. Biochemical basis for the manifestations of iron deficiency
2. Iron deficiency in the rat: Effects on oxidative metabolism in distinct types of skeletal muscle
3. Intestinal effects of iron deficiency anemia in children
4. Effect of iron deficiency on small intestinal permeability in infants and young children
5. Trace elements of the micropremie
6. Neurophysiologic evaluation of auditory recognition memory in healthy newborn infants and infants of diabetic mothers
7. Evidence of altered central nervous system development in infants with iron deficiency anemia at 6 mo: Delayed maturation of auditory brainstem responses
8. Perinatal iron deficiency and the developing brain
9. Behavior of infants with iron-deficiency anemia
10. Effect of iron-deficiency anaemia on cognitive skills in infancy and childhood
11. High iron status in very low birth weight infants is associated with an increased risk of retinopathy of prematurity
12. Reduced iron-associated antioxidants in premature newborns suffering intracerebral hemorrhage
13. Iron, oxygen stress, and the preterm infant
14. Distribution of iron and iron-binding proteins in first-trimester human pregnancies
15. Chemical development in utero
16. Storage iron in human foetal organs
17. Iron metabolism and the hypochromic anaemia of infancy
18. Iron deficiency in infancy and childhood
19. Body composition of the reference fetus
20. Prospective randomized trial of early versus late enteral iron supplementation in infants with a birth weight of less than 1301 grams
21. Fetal blood ferritin and cobalamin in normal pregnancy
22. Gestational age-dependent reference values for iron and selected proteins of iron metabolism in serum of premature human neonates
23. Plasma ferritin concentrations in preterm infants in cord blood and during the early anaemia of prematurity
24. Changes in the concentration of ferritin in the serum during fetal life in singletons and twins
25. Iron, folic acid, and vitamin B12
26. Effect of gestational age and intrauterine nutrition on plasma transferrin and iron in the newborn
27. Reduced neonatal liver iron concentrations after uteroplacental insufficiency
28. Serum ferritin in assessment of iron nutrition in healthy infants
29. Relationship of maternal and infant iron stores as assessed by determination of plasma ferritin
30. At what age does iron supplementation become necessary in low-birth-weight infants?
31. Iron status of the preterm infant during the first year of life
32. Recombinant erythropoietin for the anemia of prematurity: Still a promise, not a panacea
33. Serum ferritin in term and preterm infants
34. Iron absorption by the premature infant. The effect of transfusion and iron supplements on the serum ferritin levels
35. The effect of iron supplements and blood transfusion on iron absorption by low birthweight infants fed pasteurized human breast milk
36. Hematopoiesis and storage iron in infants
37. Iron deficiency in children: Detection and prevention
38. Ferritin turnover in plasma: An opportunistic use of blood removed during exchange transfusion
39. Recombinant human erythropoietin in the treatment of the anemia of prematurity: Results of a double-blind, placebo-controlled study
40. Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: A randomized, placebo-controlled trial
41. Intravenous iron supplementation effect on tissue iron and hemoproteins in chronically phlebotomized lambs
42. Iron supplementation enhances response to high doses of recombinant human erythropoietin in preterm infants
43. Decreased ferritin levels, despite iron supplementation, during erythropoietin therapy in anaemia of prematurity
44. Preventive effect of different dosage of recombinant human erythropoietin on anemia of premature infants
45. Blood transfusion and chronic lung disease in preterm infants
46. Serum ferritin levels in preterm infants after multiple blood transfusions
47. When is iron supplementation appropriate for extremely low birth weight infant?
48. Changing patterns of red blood cell transfusion in very low birth weight infants
49. Changing practices of red blood cell transfusions in infants with birth weight less than 1000 g
50. Prevalence of iron deficiency in the United States
51. Incidence of iron-deficiency anaemia in infants in a prospective study in Jordan
52. Plasma ferritin in the assessment of iron status of Indian infants
53. Iron nutritional status is improved in Brazilian preterm infants fed food cooked in iron pots
54. Iron status in low birth weight infants on breast and formula feeding
55. Feeding iron-fortified premature formula during initial hospitalization to infants less than 1800 grams birth weight
56. Iron deficiency in infancy and childhood
57. Iron nutritional status in preterm infants fed formulas fortified with iron
58. Ferritin in serum: Diagnosis of iron deficiency and iron overload in infants and children
59. Study of maternal influences on fetal iron status at term using cord blood transferrin receptors
60. Plasma transferrin receptor levels and indices of erythropoiesis and iron status in healthy term infants
61. Cord serum and placental tissue iron status in maternal hypoferremia
62. Neonatal prevention of iron deficiency
63. High-versus low-dose erythropoietin in extremely low birth weight infants
64. Nutritional needs of preterm infants
65. Iron absorption and red blood cell incorporation in premature infants fed an iron-fortified infant formula
66. Intravenous iron administration to very-low-birth-weight newborns receiving total and partial parenteral nutrition
67. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin treated premature infants
68. The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: A randomized, double-blind, placebo-controlled study
69. Zinc, copper, manganese, and iron balance of parenterally fed very low birth weight preterm infants receiving a trace element supplement
70. Determination of iron absorption using erythrocyte iron incorporation of two stable isotopes of iron (57Fe and 58Fe) in very low birthweight premature infants
71. Iron in the preterm infant: A pilot study comparing Fe2+ and Fe3+ tolerance and effect
72. Utilization of supplemental iron by premature infants fed fortified human milk
73. Retention of iron by infants
74. Iron absorption and incorporation into red blood cells by very low birth weight infants: Studies with the stable isotope 58Fe
75. Erythrocyte incorporation and absorption of 58Fe in premature infants treated with erythropoietin
76. Iron metabolism in premature infants. I. Absorption and utilization of iron as measured by isotope studies
77. Disorders of iron metabolism
78. Elevated intakes of zinc in infant formulas do not interfere with iron absorption in premature infants
79. Plasma zinc concentrations in iron supplemented low birthweight infants
80. Hematologic and selenium status of low-birth-weight infants fed formulas with and without iron
81. Reduced erythrocyte superoxide dismutase activity in low birth weight infants given iron supplements
82. Erythropoietin (Epo), protein and iron supplementation and the prevention of anaemia of prematurity: Effects on serum immunoreactive Epo, growth and protein and iron metabolism
83. Effect of chronic erythropoietin administration on plasma iron in newborn lambs
84. A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin
85. Iron and copper in human milk
86. Trace element content of breast-milk from mothers of preterm infants in Nigeria
87. Differences in the composition of preterm and term human milk during early lactation
88. Zinc, copper and iron content of milk from mothers of preterm and full-term infants
89. Concentration and distribution pattern of selected micronutrients in preterm and term milk from urban Brazilian mothers during early lactation
90. A comparative study of a premature infant formula and preterm breast milk for low birthweight infants
91. Effect of two levels of iron supplementation of infant formulas on developmental outcome and iron nutrition in very low birth weight infants
92. The influence of gestational age, size for dates, and prenatal steroids on cord transferrin levels in newborn infants
93. Role of dietary iron and fat on vitamin E deficiency anemia of infancy
94. Antioxidant activity, packed cell transfusions, and outcome in premature infants
95. Plasma proteins in acute and chronic lung disease of the newborn
96. Intraerythrocyte nonprotein-bound iron and plasma malondialdehyde in the hypoxic newborn
97. Hypoxia-induced free iron release in the red cells of newborn infants
98. Ferrous ions detected in iron-overloaded cord blood plasma from preterm and term babies: Implications for oxidative stress
99. Blood transfusion. Iron load and retinopathy of prematurity
100. Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity?
101. Antioxidant activity of vitamin C in iron-overloaded human plasma
102. Iron containing feeding formula and oxidative stress in preterm infants
103. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants
104. Vitamin E-dependent anemia in the premature infant. I. Effects of large doses of medicinal iron
105. Iron deficient erythropoiesis in premature infants measured by blood zinc protoporphyrin/heme
106. Clinical pharmacokinetics of iron preparations
107. Can serum ferritin be effectively interpreted in the presence of the acute-phase response?